LeadIQ logo
Learn more at LeadIQ.com

Insights

Expansion Opportunities The Cell and Gene Therapy Catapult has recently expanded its facilities in Blyth, United Kingdom, with a multi-million pound upgrade. This expansion signifies potential sales opportunities for companies providing services or products related to wind turbine testing and renewable energy innovation.

Partnership Potential Catapult's partnership with Offshore Renewable Energy Construction Advisors demonstrates a focus on collaboration and innovation in the offshore renewables sector. This partnership presents opportunities for companies specializing in offshore wind technologies or construction to explore collaboration and sales synergies with Catapult.

Financial Backing Securing significant investment and capital funding, totaling over $108 million, indicates strong financial backing for the Catapult's initiatives. This financial stability enhances its credibility and signifies potential sales opportunities for vendors offering technology solutions or services to support the Catapult's projects.

Technology Adoption With a tech stack including CUDA, PHP, C#, and other modern technologies, Catapult emphasizes technological advancement in its operations. This focus on technology adoption suggests potential sales opportunities for tech vendors to provide innovative solutions or services tailored to the biotechnology and research industry.

Innovation Sustainability Catapult's launch of new digital and automation testbeds highlights its commitment to innovation and sustainability in the cell and gene therapy industry. This focus on cutting-edge solutions presents potential sales opportunities for companies offering digital automation, testing, or related services to collaborate with Catapult.

Cell and Gene Therapy Catapult Tech Stack

Cell and Gene Therapy Catapult uses 8 technology products and services including CUDA, Culture Amp, jQuery, and more. Explore Cell and Gene Therapy Catapult's tech stack below.

  • CUDA
    Audio, Video, Graphics
  • Culture Amp
    Human Resource Management System
  • jQuery
    Javascript Libraries
  • Gravatar
    Miscellaneous
  • NextGEN Gallery
    Photo Galleries
  • PHP
    Programming Languages
  • C#
    Programming Languages
  • reCAPTCHA
    Security

Media & News

Cell and Gene Therapy Catapult's Email Address Formats

Cell and Gene Therapy Catapult uses at least 2 format(s):
Cell and Gene Therapy Catapult Email FormatsExamplePercentage
First.Last@ct.catapult.org.ukJohn.Doe@ct.catapult.org.uk
86%
FLast@ct.catapult.org.ukJDoe@ct.catapult.org.uk
10%
First.MiddleLast@ct.catapult.org.ukJohn.MichaelDoe@ct.catapult.org.uk
2%
Last@ct.catapult.org.ukDoe@ct.catapult.org.uk
1%
First.Middle@ct.catapult.org.ukJohn.Michael@ct.catapult.org.uk
1%
First.Last@catapult.org.ukJohn.Doe@catapult.org.uk
89%
FirstMiddleLast@catapult.org.ukJohnMichaelDoe@catapult.org.uk
5%
FirstLast@catapult.org.ukJohnDoe@catapult.org.uk
5%
FirLast@catapult.org.ukJohDoe@catapult.org.uk
1%

Frequently Asked Questions

Where is Cell and Gene Therapy Catapult's headquarters located?

Minus sign iconPlus sign iconCell and Gene Therapy Catapult's main headquarters is located at 12th Floor Tower Wing Guy’s Hospital London, SE1 9RT GB. The company has employees across 6 continents, including EuropeNorth AmericaAsia.

What is Cell and Gene Therapy Catapult's official website and social media links?

Minus sign iconPlus sign iconCell and Gene Therapy Catapult's official website is catapult.org.uk and has social profiles on LinkedIn.

How much revenue does Cell and Gene Therapy Catapult generate?

Minus sign iconPlus sign icon As of July 2024, Cell and Gene Therapy Catapult's annual revenue reached $75M.

What is Cell and Gene Therapy Catapult's SIC code NAICS code?

Minus sign iconPlus sign iconCell and Gene Therapy Catapult's SIC code is 7361 - Employment Agencies NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Cell and Gene Therapy Catapult have currently?

Minus sign iconPlus sign iconAs of July 2024, Cell and Gene Therapy Catapult has approximately 371 employees across 6 continents, including EuropeNorth AmericaAsia. Key team members include CTO: T. W.Chief Manufacturing Officer: S. W.Chief Clinical Officer: J. B.. Explore Cell and Gene Therapy Catapult's employee directory with LeadIQ.

What industry does Cell and Gene Therapy Catapult belong to?

Minus sign iconPlus sign iconCell and Gene Therapy Catapult operates in the Biotechnology Research industry.

What technology does Cell and Gene Therapy Catapult use?

Minus sign iconPlus sign iconCell and Gene Therapy Catapult's tech stack includes CUDACulture AmpjQueryGravatarNextGEN GalleryPHPC#reCAPTCHA.

What is Cell and Gene Therapy Catapult's email format?

Minus sign iconPlus sign iconCell and Gene Therapy Catapult's email format typically follows the pattern of . Find more Cell and Gene Therapy Catapult email formats with LeadIQ.

How much funding has Cell and Gene Therapy Catapult raised to date?

Minus sign iconPlus sign icon As of July 2024, Cell and Gene Therapy Catapult has raised $1.5M in funding. The last funding round occurred on Jun 12, 2023 for $1.5M.

When was Cell and Gene Therapy Catapult founded?

Minus sign iconPlus sign iconCell and Gene Therapy Catapult was founded in 2012.
Cell and Gene Therapy Catapult

Cell and Gene Therapy Catapult

Biotechnology ResearchLondon, United Kingdom201-500 Employees

The Cell and Gene Therapy Catapult was established as an independent centre of excellence to advance the growth of the UK cell and gene therapy industry, by bridging the gap between scientific research and full-scale commercialisation. With more than 300 employees focusing on cell and gene therapy technologies, it works with partners in academia and industry to ensure these life-changing therapies can be developed for use in health services throughout the world. It offers leading-edge capability, technology and innovation to enable companies to take products into clinical trials and provide clinical, process development, manufacturing, regulatory, health economics and market access expertise. Its aim is to make the UK the most compelling and logical choice for UK and international partners to develop and commercialise these advanced therapies. The Cell and Gene Therapy Catapult works with Innovate UK. For more information please visit ct.catapult.org.uk or visit http://www.gov.uk/innovate-uk.
The Cell and Gene Therapy Catapult works with Innovate UK. For more information please visit ct.catapult.org.uk or visit http://www.gov.uk/innovate-uk.

Section iconCompany Overview

Headquarters
12th Floor Tower Wing Guy’s Hospital London, SE1 9RT GB
Website
catapult.org.uk
SIC Code
7361 - Employment Agencies
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2012
Employees
201-500

Section iconMedia & News

Section iconFunding & Financials

  • $1.5M

    Cell and Gene Therapy Catapult has raised a total of $1.5M of funding over 5 rounds. Their latest funding round was raised on Jun 12, 2023 in the amount of $1.5M.

  • $50M$100M

    Cell and Gene Therapy Catapult's revenue is in the range of $50M$100M

Section iconFunding & Financials

  • $1.5M

    Cell and Gene Therapy Catapult has raised a total of $1.5M of funding over 5 rounds. Their latest funding round was raised on Jun 12, 2023 in the amount of $1.5M.

  • $50M$100M

    Cell and Gene Therapy Catapult's revenue is in the range of $50M$100M

Company Leadership

Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.